[go: up one dir, main page]

EA202190504A1 - Способы лечения псориаза - Google Patents

Способы лечения псориаза

Info

Publication number
EA202190504A1
EA202190504A1 EA202190504A EA202190504A EA202190504A1 EA 202190504 A1 EA202190504 A1 EA 202190504A1 EA 202190504 A EA202190504 A EA 202190504A EA 202190504 A EA202190504 A EA 202190504A EA 202190504 A1 EA202190504 A1 EA 202190504A1
Authority
EA
Eurasian Patent Office
Prior art keywords
psoriasis
treatment
methods
subunit
binds
Prior art date
Application number
EA202190504A
Other languages
English (en)
Inventor
Стюарт Уильям Фридрих
Пол Алан Клекотка
Джей Лоуренс Таттл
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA202190504A1 publication Critical patent/EA202190504A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение в целом относится к лечению псориаза антителом, которое связывает субъединицу человеческого p19 IL-23, в частности, к режимам введения для лечения заболевания.
EA202190504A 2018-09-11 2019-09-05 Способы лечения псориаза EA202190504A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862729435P 2018-09-11 2018-09-11
PCT/US2019/049648 WO2020055651A1 (en) 2018-09-11 2019-09-05 Methods of treating psoriasis

Publications (1)

Publication Number Publication Date
EA202190504A1 true EA202190504A1 (ru) 2021-06-10

Family

ID=67998728

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190504A EA202190504A1 (ru) 2018-09-11 2019-09-05 Способы лечения псориаза

Country Status (16)

Country Link
US (1) US20220064280A1 (ru)
EP (1) EP3849603A1 (ru)
JP (2) JP7203988B2 (ru)
KR (3) KR20210042138A (ru)
CN (2) CN112638420A (ru)
AU (1) AU2019337530B2 (ru)
BR (1) BR112021003209A2 (ru)
CA (1) CA3112579A1 (ru)
EA (1) EA202190504A1 (ru)
IL (2) IL319088A (ru)
MA (1) MA53602A (ru)
MX (1) MX2021002647A (ru)
SG (1) SG11202102240YA (ru)
TW (2) TWI725532B (ru)
UA (1) UA128583C2 (ru)
WO (1) WO2020055651A1 (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202224702A (zh) * 2020-09-10 2022-07-01 美商美國禮來大藥廠 治療性抗體調配物
WO2024222891A1 (zh) * 2023-04-26 2024-10-31 信达生物制药(苏州)有限公司 用重组白介素23p19抗体治疗银屑病的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3074828A (en) * 1960-02-01 1963-01-22 Mcdonnell Aircraft Corp Exothermic heated metal for heat treating and forming
KR20130130713A (ko) * 2010-10-06 2013-12-02 애브비 인코포레이티드 건선의 치료 방법
RU2591083C2 (ru) * 2010-10-08 2016-07-10 Новартис Аг Способы лечения псориаза с использованием антагонистов il-17
JOP20140049B1 (ar) 2013-03-08 2021-08-17 Lilly Co Eli أجسام مضادة ترتبط بـ il-23
WO2017221174A1 (en) * 2016-06-22 2017-12-28 Novartis Ag Methods of treating vitiligo using interleukin-17 (il-17) antibodies

Also Published As

Publication number Publication date
TWI725532B (zh) 2021-04-21
EP3849603A1 (en) 2021-07-21
AU2019337530B2 (en) 2023-08-10
MA53602A (fr) 2021-12-15
US20220064280A1 (en) 2022-03-03
TW202023615A (zh) 2020-07-01
BR112021003209A2 (pt) 2021-05-11
SG11202102240YA (en) 2021-04-29
CN112638420A (zh) 2021-04-09
KR20240168479A (ko) 2024-11-29
IL319088A (en) 2025-04-01
IL281284A (en) 2021-04-29
JP7203988B2 (ja) 2023-01-13
TW202134274A (zh) 2021-09-16
KR20230141933A (ko) 2023-10-10
CA3112579A1 (en) 2020-03-19
CN120204387A (zh) 2025-06-27
JP2023036875A (ja) 2023-03-14
WO2020055651A1 (en) 2020-03-19
TWI808397B (zh) 2023-07-11
NZ773583A (en) 2024-09-27
UA128583C2 (uk) 2024-08-21
JP2022500498A (ja) 2022-01-04
KR20210042138A (ko) 2021-04-16
MX2021002647A (es) 2021-09-14
AU2019337530A1 (en) 2021-03-18

Similar Documents

Publication Publication Date Title
SA519401522B1 (ar) Lag-3 أجـسـام مـضـادة لـ وتـركـيـبـات
MX2020008977A (es) Formulaciones de anticuerpos de her2 subcutaneas.
CR20190350A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
EA201890725A1 (ru) Агонисты фарнезоидного х-рецептора и их применение
JOP20200300A1 (ar) أجسام مضادة لـ il-11ra
CR20170600A (es) Anticuerpos del factor x1 y métodos de uso
UA118453C2 (uk) Спосіб лікування пухлин у пацієнта
MX2022002682A (es) Anticuerpos anti-cd73.
CL2017000191A1 (es) Método
JOP20190055A1 (ar) أجسام مضادة ضد cd27
MX2017015226A (es) Compuestos alqueno tetrasustituidos y su uso.
MX2022015250A (es) Un anticuerpo anti-il-23a para usarse en el tratamiento de la enfermedad de crohn.
ZA202005388B (en) Methods of treating ulcerative colitis
EA201990778A1 (ru) Анти-il-33 антитела и их применение
MX385762B (es) Métodos para el control transcripcional objetivo en regiones del super mejorador.
MX2019001958A (es) Metodos para tratar la enfermedad de crohn con un anticuerpo anti-nkg2d.
EA201790787A1 (ru) Снижение вязкости фармацевтических составов
EA201890442A1 (ru) Получение фоторецепторов для лечения заболеваний сетчатки
CL2019001749A1 (es) Uso de anticuerpos anti-esclerostina en el tratamiento de osteogenesis imperfecta.
EA201892265A1 (ru) Способы лечения офтальмологических заболеваний
EA202091112A1 (ru) Сокристаллы, фармацевтические композиции на их основе и способы лечения, предусматривающие их применение
MX380557B (es) Anticuerpos específicos para cd38 para usarse en el tratamiento de mieloma múltiple (mm).
JO3565B1 (ar) الأجسام المضادة لشبيه الأنجيوبوييتين– 4 وطرق استخدامها
MX2022011972A (es) Composiciones que comprenden anticuerpos contra il6r para el tratamiento de la uveitis y el edema macular, y metodos de uso de las mismas.
CL2021002318A1 (es) Métodos de tratamiento de amiloidosis al